UniProt ID | TPM4_HUMAN | |
---|---|---|
UniProt AC | P67936 | |
Protein Name | Tropomyosin alpha-4 chain | |
Gene Name | TPM4 | |
Organism | Homo sapiens (Human). | |
Sequence Length | 248 | |
Subcellular Localization | Cytoplasm, cytoskeleton . Associates with F-actin stress fibers. | |
Protein Description | Binds to actin filaments in muscle and non-muscle cells. Plays a central role, in association with the troponin complex, in the calcium dependent regulation of vertebrate striated muscle contraction. Smooth muscle contraction is regulated by interaction with caldesmon. In non-muscle cells is implicated in stabilizing cytoskeleton actin filaments (By similarity). Binds calcium. [PubMed: 1836432] | |
Protein Sequence | MAGLNSLEAVKRKIQALQQQADEAEDRAQGLQRELDGERERREKAEGDVAALNRRIQLVEEELDRAQERLATALQKLEEAEKAADESERGMKVIENRAMKDEEKMEIQEMQLKEAKHIAEEADRKYEEVARKLVILEGELERAEERAEVSELKCGDLEEELKNVTNNLKSLEAASEKYSEKEDKYEEEIKLLSDKLKEAETRAEFAERTVAKLEKTIDDLEEKLAQAKEENVGLHQTLDQTLNELNCI | |
Overview of Protein Modification Sites with Functional and Structural Information | ||
* ASA = Accessible Surface Area
Locations | Modification | Substrate Peptides & Secondary Structure |
ASA (%) | Reference | Orthologous Protein Cluster |
---|---|---|---|---|---|
2 | Acetylation | ------MAGLNSLEA ------CCCHHHHHH | 31.05 | 22223895 | |
6 | Phosphorylation | --MAGLNSLEAVKRK --CCCHHHHHHHHHH | 32.40 | 23401153 | |
11 | Acetylation | LNSLEAVKRKIQALQ HHHHHHHHHHHHHHH | 55.83 | 23749302 | |
11 | Ubiquitination | LNSLEAVKRKIQALQ HHHHHHHHHHHHHHH | 55.83 | - | |
11 | Malonylation | LNSLEAVKRKIQALQ HHHHHHHHHHHHHHH | 55.83 | 26320211 | |
13 | Ubiquitination | SLEAVKRKIQALQQQ HHHHHHHHHHHHHHH | 33.19 | - | |
13 | Malonylation | SLEAVKRKIQALQQQ HHHHHHHHHHHHHHH | 33.19 | 26320211 | |
13 (in isoform 1) | Ubiquitination | - | 33.19 | 21890473 | |
27 | Methylation | QADEAEDRAQGLQRE HHHHHHHHHHHHHHH | 21.95 | 115918825 | |
30 (in isoform 2) | Ubiquitination | - | 23.85 | - | |
37 (in isoform 2) | Ubiquitination | - | 48.78 | - | |
44 | Malonylation | GERERREKAEGDVAA HHHHHHHHHHHHHHH | 50.34 | 26320211 | |
44 | Acetylation | GERERREKAEGDVAA HHHHHHHHHHHHHHH | 50.34 | 25953088 | |
61 (in isoform 2) | Phosphorylation | - | 57.28 | 28985074 | |
72 | Phosphorylation | RAQERLATALQKLEE HHHHHHHHHHHHHHH | 32.28 | 24692096 | |
76 | Acetylation | RLATALQKLEEAEKA HHHHHHHHHHHHHHH | 59.73 | 22632919 | |
76 | Ubiquitination | RLATALQKLEEAEKA HHHHHHHHHHHHHHH | 59.73 | - | |
79 (in isoform 2) | Phosphorylation | - | 72.98 | 26657352 | |
82 (in isoform 1) | Ubiquitination | - | 56.79 | 21890473 | |
82 | Acetylation | QKLEEAEKAADESER HHHHHHHHHHHHHHH | 56.79 | 88217 | |
82 | Ubiquitination | QKLEEAEKAADESER HHHHHHHHHHHHHHH | 56.79 | 21906983 | |
87 | Phosphorylation | AEKAADESERGMKVI HHHHHHHHHHHHHHH | 32.89 | 26437602 | |
92 | Sumoylation | DESERGMKVIENRAM HHHHHHHHHHHHHHC | 42.77 | - | |
92 | Sumoylation | DESERGMKVIENRAM HHHHHHHHHHHHHHC | 42.77 | - | |
92 | Ubiquitination | DESERGMKVIENRAM HHHHHHHHHHHHHHC | 42.77 | - | |
100 | Ubiquitination | VIENRAMKDEEKMEI HHHHHHCCHHHHHHH | 62.09 | - | |
105 | Sulfoxidation | AMKDEEKMEIQEMQL HCCHHHHHHHHHHHH | 6.58 | 21406390 | |
113 | Ubiquitination | EIQEMQLKEAKHIAE HHHHHHHHHHHHHHH | 38.44 | - | |
116 | Ubiquitination | EMQLKEAKHIAEEAD HHHHHHHHHHHHHHH | 36.31 | - | |
116 | Acetylation | EMQLKEAKHIAEEAD HHHHHHHHHHHHHHH | 36.31 | 7719623 | |
118 (in isoform 2) | Ubiquitination | - | 5.20 | 21890473 | |
124 | Methylation | HIAEEADRKYEEVAR HHHHHHHHHHHHHHH | 50.97 | - | |
125 | Acetylation | IAEEADRKYEEVARK HHHHHHHHHHHHHHH | 58.52 | 22632901 | |
126 | Phosphorylation | AEEADRKYEEVARKL HHHHHHHHHHHHHHH | 20.44 | 21082442 | |
132 (in isoform 1) | Ubiquitination | - | 37.05 | 21890473 | |
132 | Ubiquitination | KYEEVARKLVILEGE HHHHHHHHHHHHHHH | 37.05 | - | |
153 | Acetylation | RAEVSELKCGDLEEE HHHHHHCCCCCHHHH | 31.92 | 25953088 | |
153 | Ubiquitination | RAEVSELKCGDLEEE HHHHHHCCCCCHHHH | 31.92 | - | |
154 | S-nitrosocysteine | AEVSELKCGDLEEEL HHHHHCCCCCHHHHH | 8.84 | - | |
154 | S-nitrosylation | AEVSELKCGDLEEEL HHHHHCCCCCHHHHH | 8.84 | 20140087 | |
154 | Glutathionylation | AEVSELKCGDLEEEL HHHHHCCCCCHHHHH | 8.84 | 22555962 | |
162 | Ubiquitination | GDLEEELKNVTNNLK CCHHHHHHHHHHHHH | 53.29 | - | |
165 | Phosphorylation | EEELKNVTNNLKSLE HHHHHHHHHHHHHHH | 27.99 | 26657352 | |
168 (in isoform 2) | Ubiquitination | - | 4.29 | 21890473 | |
169 | Malonylation | KNVTNNLKSLEAASE HHHHHHHHHHHHHHH | 55.93 | 26320211 | |
169 | Ubiquitination | KNVTNNLKSLEAASE HHHHHHHHHHHHHHH | 55.93 | 21890473 | |
170 | Phosphorylation | NVTNNLKSLEAASEK HHHHHHHHHHHHHHH | 34.31 | 25849741 | |
175 | Phosphorylation | LKSLEAASEKYSEKE HHHHHHHHHHHHHHH | 41.49 | 30108239 | |
177 | Acetylation | SLEAASEKYSEKEDK HHHHHHHHHHHHHHH | 52.13 | 19608861 | |
177 | Ubiquitination | SLEAASEKYSEKEDK HHHHHHHHHHHHHHH | 52.13 | 19608861 | |
177 (in isoform 1) | Ubiquitination | - | 52.13 | 21890473 | |
178 | Phosphorylation | LEAASEKYSEKEDKY HHHHHHHHHHHHHHH | 20.29 | 26657352 | |
179 | Phosphorylation | EAASEKYSEKEDKYE HHHHHHHHHHHHHHH | 53.94 | 25849741 | |
181 | Acetylation | ASEKYSEKEDKYEEE HHHHHHHHHHHHHHH | 66.33 | 26051181 | |
181 | Malonylation | ASEKYSEKEDKYEEE HHHHHHHHHHHHHHH | 66.33 | 26320211 | |
184 | Methylation | KYSEKEDKYEEEIKL HHHHHHHHHHHHHHH | 56.50 | 22632913 | |
184 | Acetylation | KYSEKEDKYEEEIKL HHHHHHHHHHHHHHH | 56.50 | 26051181 | |
184 | Ubiquitination | KYSEKEDKYEEEIKL HHHHHHHHHHHHHHH | 56.50 | 21906983 | |
184 (in isoform 1) | Ubiquitination | - | 56.50 | 21890473 | |
185 | Phosphorylation | YSEKEDKYEEEIKLL HHHHHHHHHHHHHHH | 40.68 | 26437602 | |
190 | Ubiquitination | DKYEEEIKLLSDKLK HHHHHHHHHHHHHHH | 46.81 | 21890473 | |
195 | Ubiquitination | EIKLLSDKLKEAETR HHHHHHHHHHHHHHH | 59.07 | - | |
195 | Malonylation | EIKLLSDKLKEAETR HHHHHHHHHHHHHHH | 59.07 | 26320211 | |
197 | Ubiquitination | KLLSDKLKEAETRAE HHHHHHHHHHHHHHH | 61.70 | - | |
201 | Phosphorylation | DKLKEAETRAEFAER HHHHHHHHHHHHHHH | 42.08 | 26437602 | |
209 | Phosphorylation | RAEFAERTVAKLEKT HHHHHHHHHHHHHHH | 19.13 | 21601212 | |
212 | Ubiquitination | FAERTVAKLEKTIDD HHHHHHHHHHHHHHH | 53.49 | - | |
212 | Acetylation | FAERTVAKLEKTIDD HHHHHHHHHHHHHHH | 53.49 | 25953088 | |
213 (in isoform 2) | Ubiquitination | - | 6.18 | 21890473 | |
213 | Acetylation | AERTVAKLEKTIDDL HHHHHHHHHHHHHHH | 6.18 | 19608861 | |
213 | Ubiquitination | AERTVAKLEKTIDDL HHHHHHHHHHHHHHH | 6.18 | 19608861 | |
215 | Malonylation | RTVAKLEKTIDDLEE HHHHHHHHHHHHHHH | 62.31 | 26320211 | |
215 | Acetylation | RTVAKLEKTIDDLEE HHHHHHHHHHHHHHH | 62.31 | 19608861 | |
215 (in isoform 1) | Ubiquitination | - | 62.31 | 21890473 | |
215 | Ubiquitination | RTVAKLEKTIDDLEE HHHHHHHHHHHHHHH | 62.31 | - | |
216 | Phosphorylation | TVAKLEKTIDDLEEK HHHHHHHHHHHHHHH | 21.91 | 29255136 | |
220 (in isoform 2) | Ubiquitination | - | 8.98 | 21890473 | |
223 | Malonylation | TIDDLEEKLAQAKEE HHHHHHHHHHHHHHH | 39.48 | 26320211 | |
223 | Acetylation | TIDDLEEKLAQAKEE HHHHHHHHHHHHHHH | 39.48 | 23236377 | |
223 | Ubiquitination | TIDDLEEKLAQAKEE HHHHHHHHHHHHHHH | 39.48 | - | |
228 | Ubiquitination | EEKLAQAKEENVGLH HHHHHHHHHHCCCHH | 54.18 | - | |
237 | Phosphorylation | ENVGLHQTLDQTLNE HCCCHHHHHHHHHHH | 22.89 | 30576142 | |
241 | Phosphorylation | LHQTLDQTLNELNCI HHHHHHHHHHHHCCC | 31.08 | 30576142 | |
247 | Glutathionylation | QTLNELNCI------ HHHHHHCCC------ | 6.45 | 22555962 | |
251 (in isoform 2) | Ubiquitination | - | 21890473 | ||
251 | Ubiquitination | ELNCI---------- HHCCC---------- | 19608861 | ||
251 | Acetylation | ELNCI---------- HHCCC---------- | 19608861 |
Modified Location | Modified Residue | Modification | Function | Reference | ||
---|---|---|---|---|---|---|
Oops, there are no descriptions of PTM sites of TPM4_HUMAN !! |
* Distance = the distance between SAP position and PTM sites.
Modified Location | Modification | Variant Position (Distance <= 10) |
Residue Change | SAP | Related Disease | Reference |
---|---|---|---|---|---|---|
Oops, there are no SNP-PTM records of TPM4_HUMAN !! |
Interacting Protein | Gene Name | Interaction Type | PPI Reference | Domain-Domain Interactions |
---|---|---|---|---|
ZYX_HUMAN | ZYX | physical | 22939629 | |
CAP1_HUMAN | CAP1 | physical | 22863883 | |
FAS_HUMAN | FASN | physical | 22863883 | |
LNX1_HUMAN | LNX1 | physical | 25416956 | |
ACTN1_HUMAN | ACTN1 | physical | 26344197 | |
ACTN2_HUMAN | ACTN2 | physical | 26344197 | |
COX5A_HUMAN | COX5A | physical | 26344197 | |
OSTF1_HUMAN | OSTF1 | physical | 26344197 |
Kegg Disease | ||||||
---|---|---|---|---|---|---|
There are no disease associations of PTM sites. | ||||||
OMIM Disease | ||||||
There are no disease associations of PTM sites. | ||||||
Kegg Drug | ||||||
There are no disease associations of PTM sites. | ||||||
DrugBank | ||||||
There are no disease associations of PTM sites. |
loading...
Acetylation | |
Reference | PubMed |
"Lys-N and trypsin cover complementary parts of the phosphoproteome ina refined SCX-based approach."; Gauci S., Helbig A.O., Slijper M., Krijgsveld J., Heck A.J.,Mohammed S.; Anal. Chem. 81:4493-4501(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT ALA-2, AND MASS SPECTROMETRY. | |
"Lysine acetylation targets protein complexes and co-regulates majorcellular functions."; Choudhary C., Kumar C., Gnad F., Nielsen M.L., Rehman M., Walther T.,Olsen J.V., Mann M.; Science 325:834-840(2009). Cited for: ACETYLATION [LARGE SCALE ANALYSIS] AT LYS-76; LYS-125; LYS-177;LYS-184 AND LYS-215, AND MASS SPECTROMETRY. | |
Phosphorylation | |
Reference | PubMed |
"Global survey of phosphotyrosine signaling identifies oncogenickinases in lung cancer."; Rikova K., Guo A., Zeng Q., Possemato A., Yu J., Haack H., Nardone J.,Lee K., Reeves C., Li Y., Hu Y., Tan Z., Stokes M., Sullivan L.,Mitchell J., Wetzel R., Macneill J., Ren J.M., Yuan J.,Bakalarski C.E., Villen J., Kornhauser J.M., Smith B., Li D., Zhou X.,Gygi S.P., Gu T.-L., Polakiewicz R.D., Rush J., Comb M.J.; Cell 131:1190-1203(2007). Cited for: PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT TYR-126, AND MASSSPECTROMETRY. |